Home › Funds › Seven Fleet Capital Management LP › NERV
Seven Fleet Capital Management LP position in NERV
MINERVA NEUROSCIENCES INC · Health Care
Seven Fleet Capital Management LP reported holding 1,001,373 shares of NERV (MINERVA NEUROSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$5.6M, representing 0.92% of its reported portfolio and ranking #26 among its reported holdings. Seven Fleet Capital Management LP has disclosed NERV holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Seven Fleet Capital Management LP's NERV position evolved
Seven Fleet Capital Management LP first disclosed a stake in NERV in Q1 2026 at 248,476 shares (US$1.5M). The position peaked in Q2 2026 at 1,001,373 shares, worth US$5.6M. Across 2 filings, Seven Fleet Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,001,373 shares valued at US$5.6M — an increase of 752,897 shares quarter over quarter.. Notable position changes include a 303% increase in Q2 2026 (shares fell 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 248.48K | $1.50M | New |
| Q2 2026 | 1.00M | $5.56M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NERV and 13F data
NERV (MINERVA NEUROSCIENCES INC) is a Health Care company. 56 other funds we track also report a position in NERV — the largest reported positions include Vivo Capital, LLC (US$24.0M), Logos Global Management LP (US$18.3M), Ally Bridge Group (NY) LLC (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NERV
- Vivo Capital, LLC 4.32M sh · $23.99M · Q2 2026
- Logos Global Management LP 3.29M sh · $18.25M · Q2 2026
- Ally Bridge Group (NY) LLC 2.18M sh · $12.08M · Q2 2026
- Foresite Capital Management VI LLC 1.99M sh · $11.02M · Q2 2026
- Spruce Street Capital LP 1.66M sh · $9.19M · Q2 2026
- Trails Edge Capital Partners, LP 1.42M sh · $7.88M · Q2 2026
- DV EQUITIES, LLC 754.40K sh · $4.19M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 709.50K sh · $3.94M · Q2 2026
More on Seven Fleet Capital Management LP
FAQ
How long has Seven Fleet Capital Management LP held NERV?
Seven Fleet Capital Management LP has disclosed NERV holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Seven Fleet Capital Management LP's current position in NERV?
As of Q2 2026, Seven Fleet Capital Management LP holds 1.00M shares of NERV (MINERVA NEUROSCIENCES INC), valued at $5.56M, representing 0.92% of its reported portfolio and ranking #26.
Has Seven Fleet Capital Management LP been buying or selling NERV?
In the latest 13F filing (Q2 2026), Seven Fleet Capital Management LP increased its position in NERV. The position peaked in Q2 2026 at 1.00M shares.
Which other funds hold NERV?
Other major institutional holders of NERV include Vivo Capital, LLC, Logos Global Management LP, Ally Bridge Group (NY) LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.